Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and its affiliates, has reached an agreement with the Attorney General of West Virginia that settles the state’s and its subdivisions opioid-related claims.
read more
Wednesday, February 24, 2016
Teva Pharmaceutical Industries is embarking on a strategic enterprise-wide corporate identity program to build a global brand.
read more
Monday, September 11, 2017
Teva Pharmaceutical announced its Board of Directors has named Kåre Schultz to become the company’s President and Chief Executive Officer.
read more
Wednesday, February 20, 2019
Teva Pharmaceutical announced a settlement with the Federal Trade Commission (FTC) that will resolve all outstanding litigation between the parties.
read more
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
read more
Thursday, December 27, 2018
Teva Pharmaceutical announced the launch of a generic version of Elidel1 (pimecrolimus) Cream, 1% in the U.S.
read more
Friday, February 16, 2018
Teva announced QVAR RediHaler Inhalation Aerosol is now commercially available to patients in both 40 mcg and 80 mcg strengths by prescription in the U.S.
read more
Teva Pharmaceutical Industries has agreed to sell assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited (a subsidiary of Intas Pharmaceuticals Ltd) for an agreed value of GBP 603 million, subject to final ...
read more
Friday, December 15, 2017
Teva Pharmaceutical announced a restructuring plan to significantly reduce its cost base, which includes laying off 14,000 employees worldwide.
read more
Wednesday, October 02, 2019
Teva Pharmaceutical announced the retirement of Dr. Carlo de Notaristefani, and the appointment of Eric Drapé as Executive Vice President, Global Operations.
read more
HitGen announced the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.
read more
Teva Pharmaceutical announced the launch of a generic version of Ranexa® (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S.
read more
Friday, December 15, 2017
Teva Pharmaceutical announced the exclusive launch of generic Viread tablets 300 mg in the U.S.
read more
Wednesday, August 07, 2019
Teva announced Michael McClellan, Executive Vice President and Chief Financial Officer (CFO), has decided to step down from his role as CFO due to personal reasons.
read more
Thursday, November 20, 2025
TetraScience announced that Bayer AG will expand its deployment of TetraScience's Scientific Data Foundry across its pharmaceutical and crop science R&D operations.
read more